Literature DB >> 21255803

Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data.

Lynn L Woo1, Stacy T Tanaka, Govindaraj Anumanthan, John C Pope, John C Thomas, Mark C Adams, John W Brock, Neil A Bhowmick.   

Abstract

PURPOSE: Mesenchymal stem cells have various therapeutic benefits in various organ injury models. Bladder outlet obstruction causes smooth muscle hypertrophy and fibrosis, leading to lowered compliance, increased storage pressures and renal injury. Decreased blood flow and hypoxia may contribute to obstruction related bladder decompensation. We used a mouse model to determine whether mesenchymal stem cell recruitment occurred after bladder outlet obstruction and whether this was associated with changes in bladder hypoxia, histology and function. We also identified potential chemokines involved in mesenchymal stem cell recruitment.
MATERIALS AND METHODS: A total of 20 female mice underwent bladder outlet obstruction. Three days later 2 million green fluorescent protein labeled mesenchymal stem cells were intravenously administered. After 4 weeks urodynamic and histological evaluation was performed. Quantitative reverse transcriptase-polymerase chain reaction was done to determine relative expression of the chemokines CCL2, CCL20, CCL25, CXCL9 and CXCL16. We simultaneously studied mice with bladder outlet obstruction only without mesenchymal stem cell injection and a control group.
RESULTS: In 10 of 15 surviving mesenchymal stem cell injected mice mesenchymal stem cells were identified in the detrusor, and decreased hypoxia, hypertrophy and fibrosis was seen. Nine of 10 mice with mesenchymal stem cell engraftment had improved compliance compared to those without engraftment (mean±SD 9.6±5.1 vs 3.9±2.6 μl/cm H2O, p=0.012). Polymerase chain reaction revealed a 2-fold increase in CCL2 expression but there were no significant changes in other chemokine levels.
CONCLUSIONS: Mesenchymal stem cell recruitment to the bladder after bladder outlet obstruction appears to be associated with increased blood flow and decreased tissue hypoxia, which may contribute to improvement in histopathological and functional parameters. Mesenchymal stem cell recruitment may be related to CCL2 over expression. Additional studies in larger samples are needed but these initial results suggest a potential role for mesenchymal stem cell based therapy for bladder outlet obstruction related bladder injury.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21255803     DOI: 10.1016/j.juro.2010.10.033

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²⁺ signaling regulators.

Authors:  David Burmeister; Tamer AbouShwareb; Ralph D'Agostino; Karl-Erik Andersson; George J Christ
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-21

Review 2.  Stem Cell Therapy: Current Applications and Potential for Urology.

Authors:  Bridget Wiafe; Peter D Metcalfe; Adetola B Adesida
Journal:  Curr Urol Rep       Date:  2015-11       Impact factor: 3.092

Review 3.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

Review 4.  Regenerative medicine based applications to combat stress urinary incontinence.

Authors:  Hatim Thaker; Arun K Sharma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 5.  Bone marrow mesenchymal stem cell therapy for voiding dysfunction.

Authors:  Alice Yu; Lysanne Campeau
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

6.  The histopathologic, pharmacologic and urodynamic results of mesenchymal stem cell's injection into the decompensated rabbit's bladder.

Authors:  Murat Dayanc; Yusuf Kibar; Ali U Ural; Onder Onguru; Oguzhan Yildiz; Hasan C Irkilata; Ferit Avcu; Burak C Soner; Cunay Ulku; Melik Seyrek
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

7.  Stem cell therapy for the bladder--where do we stand?

Authors:  Ching-Shwun Lin
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

8.  Chronic cyclic bladder over distention up-regulates hypoxia dependent pathways.

Authors:  Heidi A Stephany; Douglas W Strand; Christina B Ching; Stacy T Tanaka; Ginger L Milne; Mariana M Cajaiba; John C Thomas; John C Pope; Mark C Adams; John W Brock; Simon W Hayward; Robert J Matusik; Douglass B Clayton
Journal:  J Urol       Date:  2013-02-19       Impact factor: 7.450

Review 9.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

Review 10.  The potential role of stem cells in the treatment of urinary incontinence.

Authors:  Christine Tran; Margot S Damaser
Journal:  Ther Adv Urol       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.